JP2022541788A5 - - Google Patents

Info

Publication number
JP2022541788A5
JP2022541788A5 JP2022503015A JP2022503015A JP2022541788A5 JP 2022541788 A5 JP2022541788 A5 JP 2022541788A5 JP 2022503015 A JP2022503015 A JP 2022503015A JP 2022503015 A JP2022503015 A JP 2022503015A JP 2022541788 A5 JP2022541788 A5 JP 2022541788A5
Authority
JP
Japan
Prior art keywords
cells
int
isolated
phenotype
cd45ro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022503015A
Other languages
English (en)
Japanese (ja)
Other versions
JP7798762B2 (ja
JP2022541788A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/042567 external-priority patent/WO2021011882A1/en
Publication of JP2022541788A publication Critical patent/JP2022541788A/ja
Publication of JP2022541788A5 publication Critical patent/JP2022541788A5/ja
Priority to JP2025281458A priority Critical patent/JP2026053611A/ja
Application granted granted Critical
Publication of JP7798762B2 publication Critical patent/JP7798762B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022503015A 2019-07-17 2020-07-17 Hiv感染症を治療するための長寿命t細胞 Active JP7798762B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025281458A JP2026053611A (ja) 2019-07-17 2025-12-25 Hiv感染症を治療するための長寿命t細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962875217P 2019-07-17 2019-07-17
US62/875,217 2019-07-17
PCT/US2020/042567 WO2021011882A1 (en) 2019-07-17 2020-07-17 Long lived t cells for treating hiv infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025281458A Division JP2026053611A (ja) 2019-07-17 2025-12-25 Hiv感染症を治療するための長寿命t細胞

Publications (3)

Publication Number Publication Date
JP2022541788A JP2022541788A (ja) 2022-09-27
JP2022541788A5 true JP2022541788A5 (https=) 2023-07-25
JP7798762B2 JP7798762B2 (ja) 2026-01-14

Family

ID=74209988

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022503015A Active JP7798762B2 (ja) 2019-07-17 2020-07-17 Hiv感染症を治療するための長寿命t細胞
JP2025281458A Pending JP2026053611A (ja) 2019-07-17 2025-12-25 Hiv感染症を治療するための長寿命t細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025281458A Pending JP2026053611A (ja) 2019-07-17 2025-12-25 Hiv感染症を治療するための長寿命t細胞

Country Status (10)

Country Link
US (1) US20230149457A1 (https=)
EP (1) EP3999187A4 (https=)
JP (2) JP7798762B2 (https=)
KR (1) KR20220073729A (https=)
CN (1) CN114728181B (https=)
AU (1) AU2020314956A1 (https=)
CA (1) CA3144413A1 (https=)
IL (1) IL289935A (https=)
WO (1) WO2021011882A1 (https=)
ZA (1) ZA202201930B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3158133A1 (en) 2020-04-28 2021-11-04 Lyell Immunopharma, Inc. Methods for culturing cells
CN118235740B (zh) * 2024-04-30 2025-11-21 华中农业大学 一种通过向饲料中添加异戊酸钠缓解慢性束缚应激对动物不良影响的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010902A (en) * 1988-04-04 2000-01-04 Bristol-Meyers Squibb Company Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
US6432405B1 (en) * 1991-03-15 2002-08-13 Duke University Method of inhibiting HIV infection with CD44 and anti-CD44 antibodies
US6692964B1 (en) * 1995-05-04 2004-02-17 The United States Of America As Represented By The Secretary Of The Navy Methods for transfecting T cells
AU2002322211A1 (en) * 2001-07-12 2003-01-29 Canvac Methods and compisitions for activation human t cells in vitro
ES2465996T3 (es) * 2006-05-25 2014-06-09 Sangamo Biosciences, Inc. Métodos y composiciones para la inactivación genética
WO2009036521A1 (en) * 2007-09-20 2009-03-26 St Vincent's Hospital Sydney Limited A method for identifying antigen-specific regulatory t cells
CN102247590A (zh) * 2010-05-18 2011-11-23 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药物组合及其应用
WO2012092578A1 (en) * 2010-12-31 2012-07-05 The Trustees Of Columbia University In The City Of New York Generation of autologous t-cells in mice
IL297773B2 (en) * 2014-11-17 2024-07-01 Adicet Bio Inc Engineered gamma delta t-cells
US20190136230A1 (en) * 2016-05-06 2019-05-09 Juno Therapeutics, Inc. Genetically engineered cells and methods of making the same
WO2019070755A1 (en) * 2017-10-02 2019-04-11 The Broad Institute, Inc. METHODS AND COMPOSITIONS FOR DETECTING AND MODULATING A GENETIC SIGNATURE OF IMMUNOTHERAPY RESISTANCE IN CANCER
KR20200135852A (ko) * 2018-03-27 2020-12-03 아메리칸 진 테크놀로지스 인터내셔널 인코포레이티드 유전자 변형 림프구의 제조 방법
CA3100837A1 (en) * 2018-05-15 2019-11-21 Case Western Reserve University Long lived chimeric antigen receptor (car) expressing t cells for cancer therapy

Similar Documents

Publication Publication Date Title
US20240415963A1 (en) T cells for expression of chimeric antigen receptors and other receptors
Banga et al. Blood CXCR3+ CD4 T cells are enriched in inducible replication competent HIV in aviremic antiretroviral therapy-treated individuals
Granzin et al. Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
McHeyzer-Williams et al. Class-switched memory B cells remodel BCRs within secondary germinal centers
Vidya Vijayan et al. Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections
Kohn et al. Lymphoid priming in human bone marrow begins before expression of CD10 with upregulation of L-selectin
JP2021509586A5 (https=)
RU2017127051A (ru) Способы получения экспрессирующих химерный антигенный рецептор клеток
JP2017514517A5 (https=)
JP2023501617A5 (https=)
JP2016509840A5 (https=)
JP2022554348A5 (https=)
JP2022541788A5 (https=)
Karlsson et al. FoxP3+ CD25+ CD8+ T-cell induction during primary simian immunodeficiency virus infection in cynomolgus macaques correlates with low CD4+ T-cell activation and high viral load
US20240228959A9 (en) Large scale car-t immune cell manufacturing method utilizing lentiviral vector transfection
JP2024519029A5 (https=)
JPWO2012096376A1 (ja) 制御性t細胞の製造方法
JP2024515064A5 (https=)
Charbord et al. Analysis of the microenvironment necessary for engraftment: role of the vascular smooth muscle-like stromal cells
Chaichompoo et al. Multiple KIR gene polymorphisms are associated with plasma viral loads in SIV-infected rhesus macaques
US11649429B2 (en) Mutant algal strain and methods thereof
JP2023530419A5 (https=)
Muñoz et al. Ex vivo expansion and lentiviral transduction of Macaca nemestrina CD4+ T cells
JPWO2021100585A5 (https=)
Nohara Characterizing the Functional Profile of NK Cells Engaged by Antibodies